Endocrinology 

Articles

The novel prandial insulin formulation from Eli Lilly is now approved for administration via continuous subcutaneous insulin infusion with an insulin pump. 

FDA Grants Insulin Lispro-aabc Label Expansion for use in Insulin Pumps 

COVID-19 patients with hyperglycemia on hospital admission, with and without diabetes, had increased odds of intubation, ICU admission, and mortality, according to research presented at ENDO 2021. 

Hyperglycemia in Hospitalized COVID-19 Patients Linked with Worse Outcomes

ENDO 2021: An investigational once-weekly insulin formulation was found as effective as daily basal insulin injection for glucose control with lower rates of hypoglycemia and less weight gain. 

Novel Once-weekly Insulin as Effective as Once-daily in Type 2 Diabetes with Less Hypoglycemia, Weight Gain  

Videos

Insulin affordability is an ongoing discussion topic for patients with diabetes and their care providers. The already difficult issue has been further compounded by the ongoing COVID-19 pandemic.  

Diana Isaacs, PharmD: An Overview of Insulin Affordability in 2020

Slideshows

Three patients with type 2 diabetes in different stages of life and disease all require insulin management for A1c control. 

Issues in Insulin Management: 3 Cases of Type 2 Diabetes 

Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017. 

ADA 2017: Insulins go Head-to-Head 

Stringent control was supported even in patients at high risk for related harm. Reasons found for concern over Rx "deintensification" may surprise you. 

Primary Care Docs Prefer Tight Glucose Control in T2D

Here’s a look at what’s new and interesting on the Web for health care professionals.

Batting Averages and Sex Improvement

Maintaining tight glycemic control in older diabetic adults who are in poor health can do far more harm than good, according to results of a new study. 

Diabetes Control Too Tight for Some Older Adults

Activation of opioid receptors with novel approaches may prevent hypoglycemia and lead to safer intensive glycemic control, according to a study reported at the American Diabetes Association 74th Scientific Sessions.